BioRender 图标

Pneumocyte (type I) 2

Pneumocyte (type I) 2 - Editable icon of a flat and thin type I pneumocytes with a nucleus
[{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3681b/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3681b/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3681c/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3681c/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3681d/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3681d/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3681e/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3681e/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3681f/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3681f/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36820/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36820/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36821/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36821/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36822/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36822/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36823/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36823/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36824/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36824/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36825/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36825/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36826/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36826/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36827/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36827/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36828/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36828/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36829/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36829/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3682a/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3682a/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3682b/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3682b/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3682c/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3682c/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3682d/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3682d/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3682e/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3682e/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3682f/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3682f/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36830/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36830/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36831/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36831/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36832/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36832/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36833/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36833/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36834/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36834/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36835/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36835/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36836/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36836/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36837/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36837/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36838/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36838/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36839/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36839/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3683a/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3683a/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3683b/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3683b/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3683c/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3683c/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3683d/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3683d/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3683e/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3683e/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3683f/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3683f/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36840/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36840/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36841/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36841/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36842/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36842/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36843/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36843/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36844/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36844/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36845/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36845/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36846/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36846/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36847/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36847/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36848/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36848/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb36849/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb36849/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3684a/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3684a/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3684b/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3684b/5be1f9056f3d0b12005a9ad9.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fa693ccf015b9bb3684c/5be1f9056f3d0b12005a9ad9.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fa693ccf015b9bb3684c/5be1f9056f3d0b12005a9ad9.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
respiratory system,respiration,alveoli,alveolar,gas exchange,pneumocyte,type 1 pneumocyte,type I pneumocyte,type 1 alveolar cell,type I alveolar cell,alveolar cell
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Pneumocyte (type I) 2 icon JPEG

Pneumocyte (type I) 2 icon PNG

Pneumocyte (type I) 2 icon SVG

Pneumocyte (type I) 2 icon GIF

BioRender 图标常见问题解答

How are scientists using the Pneumocyte (type I) 2 icon in their work?

BioRender users often use the Pneumocyte (type I) 2 icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Pneumocyte (type I) 2 is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Pneumocyte (type I) 2 icon customizable in BioRender?

Most icons in BioRender, including the Pneumocyte (type I) 2 icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Pneumocyte (type I) 2 icon for publication or presentations?

Yes, figures containing the Pneumocyte (type I) 2 icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Pneumocyte (type I) 2 icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Pneumocyte (type I) 2 icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Pneumocyte (type I) 2 icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon